SomaServe
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $28M
Investors
- 8
About SomaServe
Founded in 2018 and headquartered in Cambridge, UK, SomaServe, Ltd specializes in the creation of genetic nanomedicines.00 mn on November 13, 2023.SomaServe, Ltd focuses on developing genetic nanomedicines primarily through its proprietary polyNaut® platform. This technology enables the creation of non-immunogenic nanovesicles for the targeted delivery of genetic therapies, including mRNA, siRNA, and gene editing, directly to tissues and cells.SomaServe, Ltd generates revenue by forming strategic collaborations with biotech and pharmaceutical firms, facilitating the co-development of products through its polyNaut® platform. Revenue is derived from project-based transactions, including payments for research and development services, milestone achievements, and licensing fees. The company seeks to expand its market presence across North America and Europe, where demand for genetic therapies is growing. Furthermore, ongoing efforts are being made to design innovative products that will be launched in the upcoming years, enhancing its portfolio and strengthening its position in the biotechnology landscape.
Who invested in SomaServe
8 investors across 3 rounds
See all investors in SomaServe
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SomaServe
Who invested in SomaServe?
SomaServe has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SomaServe raised?
SomaServe has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SomaServe last raise money?
SomaServe's most recent round on record is a Series A, in Nov 2023.
What does SomaServe do?
Founded in 2018 and headquartered in Cambridge, UK, SomaServe, Ltd specializes in the creation of genetic nanomedicines.
Where is SomaServe headquartered?
SomaServe is headquartered in Cambridge, UK.
Which VCs invest in companies like SomaServe?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at SomaServe's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like SomaServe? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.